• Explore /
  • Poster
  • / A pilot study of durvalumab/tremelimumab (durva/treme) and radiation (XRT) for metastatic biliary tract cancer (mBTC): Preliminary safety and efficacy.

A pilot study of durvalumab/tremelimumab (durva/treme) and radiation (XRT) for metastatic biliary tract cancer (mBTC): Preliminary safety and efficacy.

Abstract Poster

Authors

null

Theodore S. Hong

Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA

Theodore S. Hong , Lipika Goyal , Aparna Raj Parikh , Beow Y. Yeap , Christine A. Ulysse , Lorraine C. Drapek , Jill N. Allen , Jeffrey William Clark , Benjamin Christopher , Christine Bolton , David P. Ryan , Ryan Bruce Corcoran , Jeffrey A. Meyerhardt , Jennifer Yon-Li Wo , Andrew X. Zhu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer

Track

Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03482102

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 547)

Abstract #

547

Poster Bd #

D8

Abstract Disclosures

Similar Posters

First Author: Houda Bahig

First Author: Si-Yuan Chen

First Author: Eileen Mary O'Reilly

First Author: Jieer Ying